Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Our objective is to compare the clinical correlates of serum 25-hydroxyvitamin D [25(OH)D] levels in patients with SLE and BD.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This single-centre cross-sectional study was conducted at the Rheumatology Clinic of Fırat University Hospital, Elazığ, Turkey.

Source: Methods.

All patients were aged ≥18 years.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Disease-Specific Clinical Correlates of Vitamin D in Systemic Lupus Erythematosus and Behçet’s Disease

Cross-sectional study · Medicina · 2026

Original publication title

Disease-Specific Clinical Correlates of Vitamin D in Systemic Lupus Erythematosus and Behçet’s Disease

Mustafa Gür; Ahmet Karataş; Burak Öz; Sümeyye Şahin; Yusuf Doğan; Nevzat Gözel; Süleyman Serdar Koca

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background and Objectives: Vitamin D deficiency is common in systemic lupus erythematosus (SLE) and Behçet’s disease (BD). However, whether it is associated with the same clinical parameters in both conditions remains unknown. Our objective is to compare the clinical correlates of serum 25-hydroxyvitamin D [25(OH)D] levels in patients with SLE and BD. Materials and Methods: This exploratory cross-sectional study included 38 patients with SLE and 32 with BD. Spearman’s correlation analyses, partial correlations controlling for sex, and tertile analyses were performed separately for each disease group. Results: Vitamin D deficiency [25(OH)D < 20 ng/mL] was similarly prevalent in SLE (64.9%) and BD (62.5%).

However, distinct disease-specific correlation profiles were noted. In SLE, serum 25(OH)D levels were inversely correlated with body mass index (BMI) (r = −0.47, p = 0.003) and parathyroid hormone (PTH) (r = −0.40, p = 0.01), with no significant associations with inflammatory or haematological parameters. In patients with BD, 25(OH)D levels were positively correlated with haemoglobin (r = 0.63, p < 0.001), haematocrit (r = 0.58, p < 0.001), ferritin (r = 0.47, p = 0.008), uric acid (r = 0.48, p = 0.005), transferrin saturation (r = 0.45, p = 0.02), and triglycerides (r = 0.44, p = 0.01), while they were inversely correlated with total iron-binding capacity (r = −0.50, p = 0.01) and erythrocyte sedimentation rate (ESR) (r = −0.44, p = 0.01).

After adjusting for sex, the association between 25(OH)D and haemoglobin remained significant (partial r = 0.43, p = 0.01), as did the associations with haematocrit (partial r = 0.42, p = 0.02) and triglycerides (partial r = 0.43, p = 0.02). In contrast, the correlations with ferritin, ESR, uric acid, and transferrin saturation were attenuated and no longer statistically significant. Tertile analyses demonstrated dose: response relationships between vitamin D levels and BMI (p = 0.01) and PTH (p = 0.008) in SLE, and between vitamin D levels and haemoglobin (p = 0.001) and ferritin (p = 0.02) in BD. Conclusions: Despite the similar prevalence of vitamin D deficiency, patients with SLE and BD exhibit distinct vitamin D-associated clinical profiles.

Vitamin D status was primarily associated with metabolic parameters in SLE and haematological parameters in BD. These disease-specific patterns may reflect differences in the underlying inflammatory pathways and pathophysiological mechanisms involved.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background and Objectives

Vitamin D deficiency is common in systemic lupus erythematosus (SLE) and Behçet’s disease (BD). However, whether it is associated with the same clinical parameters in both conditions remains unknown. Our objective is to compare the clinical correlates of serum 25-hydroxyvitamin D [25(OH)D] levels in patients with SLE and BD.

Source: Background and Objectives

Abstract: Results

Vitamin D deficiency [25(OH)D < 20 ng/mL] was similarly prevalent in SLE (64.9%) and BD (62.5%). However, distinct disease-specific correlation profiles were noted. In SLE, serum 25(OH)D levels were inversely correlated with body mass index (BMI) (r = −0.47, p = 0.003) and parathyroid hormone (PTH) (r = −0.40, p = 0.01), with no significant associations with inflammatory or haematological parameters. In patients with BD, 25(OH)D levels were positively correlated with haemoglobin (r = 0.63, p < 0.001), haematocrit (r = 0.58, p < 0.001), ferritin (r = 0.47, p = 0.008), uric acid (r = 0.48, p = 0.005), transferrin saturation (r = 0.45, p = 0.02), and triglycerides (r = 0.44, p = 0.01), while they were inversely correlated with total iron-binding capacity (r = −0.50, p = 0.01) and erythrocyte sedimentation rate (ESR) (r = −0.44, p = 0.01). After adjusting for sex, the association between 25(OH)D and haemoglobin remained significant (partial r = 0.43, p = 0.01), as did the associations with haematocrit (partial r = 0.42, p = 0.02) and triglycerides (partial r = 0.43, p = 0.02). In contrast, the correlations with ferritin, ESR, uric acid, and transferrin saturation were attenuated and no longer statistically significant. Tertile analyses demonstrated dose: response relationships between vitamin D levels and BMI (p = 0.01) and PTH (p = 0.008) in SLE, and between vitamin D levels and haemoglobin (p = 0.001) and ferritin (p = 0.02) in BD.

Source: Results:

Abstract: Conclusions

Despite the similar prevalence of vitamin D deficiency, patients with SLE and BD exhibit distinct vitamin D-associated clinical profiles. Vitamin D status was primarily associated with metabolic parameters in SLE and haematological parameters in BD. These disease-specific patterns may reflect differences in the underlying inflammatory pathways and pathophysiological mechanisms involved.

Source: Conclusions
Authors’ abstract

Background and Objectives: Vitamin D deficiency is common in systemic lupus erythematosus (SLE) and Behçet’s disease (BD). However, whether it is associated with the same clinical parameters in both conditions remains unknown. Our objective is to compare the clinical correlates of serum 25-hydroxyvitamin D [25(OH)D] levels in patients with SLE and BD. Materials and Methods: This exploratory cross-sectional study included 38 patients with SLE and 32 with BD. Spearman’s correlation analyses, partial correlations controlling for sex, and tertile analyses were performed separately for each disease group. Results: Vitamin D deficiency [25(OH)D < 20 ng/mL] was similarly prevalent in SLE (64.9%) and BD (62.5%).

However, distinct disease-specific correlation profiles were noted. In SLE, serum 25(OH)D levels were inversely correlated with body mass index (BMI) (r = −0.47, p = 0.003) and parathyroid hormone (PTH) (r = −0.40, p = 0.01), with no significant associations with inflammatory or haematological parameters. In patients with BD, 25(OH)D levels were positively correlated with haemoglobin (r = 0.63, p < 0.001), haematocrit (r = 0.58, p < 0.001), ferritin (r = 0.47, p = 0.008), uric acid (r = 0.48, p = 0.005), transferrin saturation (r = 0.45, p = 0.02), and triglycerides (r = 0.44, p = 0.01), while they were inversely correlated with total iron-binding capacity (r = −0.50, p = 0.01) and erythrocyte sedimentation rate (ESR) (r = −0.44, p = 0.01).

After adjusting for sex, the association between 25(OH)D and haemoglobin remained significant (partial r = 0.43, p = 0.01), as did the associations with haematocrit (partial r = 0.42, p = 0.02) and triglycerides (partial r = 0.43, p = 0.02). In contrast, the correlations with ferritin, ESR, uric acid, and transferrin saturation were attenuated and no longer statistically significant. Tertile analyses demonstrated dose: response relationships between vitamin D levels and BMI (p = 0.01) and PTH (p = 0.008) in SLE, and between vitamin D levels and haemoglobin (p = 0.001) and ferritin (p = 0.02) in BD. Conclusions: Despite the similar prevalence of vitamin D deficiency, patients with SLE and BD exhibit distinct vitamin D-associated clinical profiles.

Vitamin D status was primarily associated with metabolic parameters in SLE and haematological parameters in BD. These disease-specific patterns may reflect differences in the underlying inflammatory pathways and pathophysiological mechanisms involved.

Publication and source details

Original title: Disease-Specific Clinical Correlates of Vitamin D in Systemic Lupus Erythematosus and Behçet’s Disease

Mustafa Gür; Ahmet Karataş; Burak Öz; Sümeyye Şahin; Yusuf Doğan; Nevzat Gözel; Süleyman Serdar Koca

Medicina · 2026

* Correspondence: mustafagur@mail.com© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-07T22:00:12+00:00

DOI: 10.3390/medicina62101822 · PMC13706961